[Metabolic complications of the treatment of acute leukemia with L-asparaginase (apropos of 147 cases)].
D001215:Asparaginase / Q000009:adverse effects* / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D016883:Diabetic Ketoacidosis; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced; D006943:Hyperglycemia / Q000139:chemically induced; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D008297:Male
D008055:Lipids; D002784:Cholesterol; D001215:Asparaginase
Les complications métaboliques du traitement par la L-asparaginase des leucémies aiguës (a propos de 147 observations)